Lucia Manganaro1,2, Matteo Saldari3,4, Carlotta Pozza2,5, Valeria Vinci1, Daniele Gianfrilli2,5, Ermanno Greco6, Giorgio Franco2,7, Maria Eleonora Sergi1, Michele Scialpi8, Carlo Catalano1, Andrea M Isidori2,5. 1. Department of Department of Radiological, Oncological and Anatomo-Pathological Sciences, La Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. 2. Testis-Unit (TU), Policlinico Umberto I, Rome, Italy. 3. Department of Department of Radiological, Oncological and Anatomo-Pathological Sciences, La Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. matteo.saldari@gmail.com. 4. Testis-Unit (TU), Policlinico Umberto I, Rome, Italy. matteo.saldari@gmail.com. 5. Department of Experimental Medicine, La Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. 6. Centre for Reproductive Medicine, European Hospital, Via Portuense 700, 00148, Rome, Italy. 7. Department Gynaecological-Obstetrical and Urological Sciences, La Sapienza University of Rome, Viale Regina Elena, 324 00161, Rome, Italy. 8. Department of Surgical and Biomedical Sciences, Division of Radiology 2, Perugia University, S. Maria della Misericordia Hospital, S. Andrea delle Fratte, 06156, Perugia, Italy.
Abstract
OBJECTIVES: To explore the role of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI), using semiquantitative and quantitative parameters, and diffusion-weighted (DW) MRI in differentiating benign from malignant small, non-palpable solid testicular tumours. METHODS: We calculated the following DCE-MRI parameters of 47 small, non-palpable solid testicular tumours: peak enhancement (PE), time to peak (TTP), percentage of peak enhancement (Epeak), wash-in-rate (WIR), signal enhancement ratio (SER), volume transfer constant (Ktrans), rate constant (Kep), extravascular extracellular space volume fraction (Ve) and initial area under the curve (iAUC). DWI signal intensity and apparent diffusion coefficient (ADC) values were evaluated. RESULTS: Epeak, WIR, Ktrans , Kep and iAUC were higher and TTP shorter in benign compared to malignant lesions (p < 0.05). All tumours had similar ADC values (p > 0.07). Subgroup analysis limited to the most frequent histologies - Leydig cell tumours (LCTs) and seminomas - replicated the findings of the entire set. Best diagnostic cutoff value for identification of seminomas: Ktrans ≤0.135 min-1, Kep ≤0.45 min-1, iAUC ≤10.96, WIR ≤1.11, Epeak ≤96.72, TTP >99 s. CONCLUSIONS: DCE-MRI parameters are valuable in differentiating between benign and malignant small, non-palpable testicular tumours, especially when characterising LCTs and seminomas. KEY POINTS: • DCE-MRI may be used to differentiate benign from malignant non-palpable testicular tumours. • Seminomas show lower Ktrans, Kep and iAUC values. • ADC values are not valuable in differentiating seminomas from LCTs. • Semiquantitative DCE-MRI may be used to characterise small, solid testicular tumours.
OBJECTIVES: To explore the role of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI), using semiquantitative and quantitative parameters, and diffusion-weighted (DW) MRI in differentiating benign from malignant small, non-palpable solid testicular tumours. METHODS: We calculated the following DCE-MRI parameters of 47 small, non-palpable solid testicular tumours: peak enhancement (PE), time to peak (TTP), percentage of peak enhancement (Epeak), wash-in-rate (WIR), signal enhancement ratio (SER), volume transfer constant (Ktrans), rate constant (Kep), extravascular extracellular space volume fraction (Ve) and initial area under the curve (iAUC). DWI signal intensity and apparent diffusion coefficient (ADC) values were evaluated. RESULTS: Epeak, WIR, Ktrans , Kep and iAUC were higher and TTP shorter in benign compared to malignant lesions (p < 0.05). All tumours had similar ADC values (p > 0.07). Subgroup analysis limited to the most frequent histologies - Leydig cell tumours (LCTs) and seminomas - replicated the findings of the entire set. Best diagnostic cutoff value for identification of seminomas: Ktrans ≤0.135 min-1, Kep ≤0.45 min-1, iAUC ≤10.96, WIR ≤1.11, Epeak ≤96.72, TTP >99 s. CONCLUSIONS:DCE-MRI parameters are valuable in differentiating between benign and malignant small, non-palpable testicular tumours, especially when characterising LCTs and seminomas. KEY POINTS: • DCE-MRI may be used to differentiate benign from malignant non-palpable testicular tumours. • Seminomas show lower Ktrans, Kep and iAUC values. • ADC values are not valuable in differentiating seminomas from LCTs. • Semiquantitative DCE-MRI may be used to characterise small, solid testicular tumours.
Authors: Glen W Barrisford; Evgeniy I Kreydin; Mark A Preston; Dayron Rodriguez; Mukesh G Harisighani; Adam S Feldman Journal: Future Oncol Date: 2015-08-28 Impact factor: 3.404
Authors: William Stokes; Arya Amini; Paul D Maroni; Elizabeth R Kessler; Claire Stokes; Carrye R Cost; Brian S Greffe; Timothy P Garrington; Arthur K Liu; Nicholas G Cost Journal: J Pediatr Urol Date: 2017-01-17 Impact factor: 1.830
Authors: Andrea M Isidori; Carlotta Pozza; Daniele Gianfrilli; Elisa Giannetta; Andrea Lemma; Riccardo Pofi; Federica Barbagallo; Lucia Manganaro; Giovanni Martino; Francesco Lombardo; Vito Cantisani; Giorgio Franco; Andrea Lenzi Journal: Radiology Date: 2014-06-26 Impact factor: 11.105
Authors: M O Leach; B Morgan; P S Tofts; D L Buckley; W Huang; M A Horsfield; T L Chenevert; D J Collins; A Jackson; D Lomas; B Whitcher; L Clarke; R Plummer; I Judson; R Jones; R Alonzi; T Brunner; D M Koh; P Murphy; J C Waterton; G Parker; M J Graves; T W J Scheenen; T W Redpath; M Orton; G Karczmar; H Huisman; J Barentsz; A Padhani Journal: Eur Radiol Date: 2012-05-07 Impact factor: 5.315
Authors: Laurence Rocher; Parvati Ramchandani; Jane Belfield; Michele Bertolotto; Lorenzo E Derchi; Jean Michel Correas; Raymond Oyen; Athina C Tsili; Ahmet Tuncay Turgut; Vikram Dogra; Karim Fizazi; Simon Freeman; Jonathan Richenberg Journal: Eur Radiol Date: 2015-10-24 Impact factor: 5.315
Authors: A S Tresoldi; N Betella; V Hasenmajer; C Pozza; W Vena; B Fiamengo; L Negri; M Cappa; A G A Lania; A Lenzi; A M Isidori; A Pizzocaro Journal: J Endocrinol Invest Date: 2020-07-20 Impact factor: 4.256
Authors: Carlotta Pozza; George Kanakis; Francesco Carlomagno; Andrea Lemma; Riccardo Pofi; Marta Tenuta; Marianna Minnetti; Maria G Tarsitano; Franz Sesti; Donatella Paoli; Antonella Anzuini; Andrea Lenzi; Andrea M Isidori; Daniele Gianfrilli Journal: Andrology Date: 2020-07-02 Impact factor: 3.842
Authors: G Corona; E Baldi; A M Isidori; D Paoli; F Pallotti; L De Santis; F Francavilla; S La Vignera; R Selice; L Caponecchia; R Pivonello; A Ferlin; C Foresta; E A Jannini; A Lenzi; M Maggi; F Lombardo Journal: J Endocrinol Invest Date: 2020-05-27 Impact factor: 4.256